Read More Healthcare Industry News Why Johnson & Johnson says Tutanota’s mini-tender offer could put shareholders at risk Johnson & Johnson (NYSE: JNJ) urges investors to reject Tutanota’s mini-tender offer—find out why the bid poses risks, what it signals for governance, and how markets reacted. byPallavi MadhirajuOctober 11, 2025